CD Biosynsis delivers complete, integrated Bacillus subtilis Genome Editing and Metabolic Engineering Solutions designed to accelerate the development of high-performance microbial strains. As a leading service provider, we leverage cutting-edge synthetic biology and computational tools to transform B. subtilis into a robust, high-yield host for biomanufacturing. Our comprehensive platform covers the entire strain development pipeline, from precise Bacillus subtilis Genome Editing and advanced pathway design to strain validation and process optimization. We offer expertise in all critical areas, including: CRISPR-Cas9 Editing, Pathway Optimization, Protein Expression, and Assay and Modeling, ensuring predictable and scalable results for your industrial and research goals.
Get a QuoteOptimizing B. subtilis for high-titer production requires a synergy between precise genetic engineering and deep metabolic understanding. Our solutions are built upon the modern Design-Build-Test-Learn (DBTL) framework. We start with rational design guided by computational modeling, utilize advanced CRISPR tools for building the engineered strains, and employ high-throughput screening and functional assays to test and validate performance. This integrated strategy is the most efficient way to enhance product yield, eliminate metabolic bottlenecks, improve protein secretion, and guarantee the genetic stability of your industrial host, whether you are developing novel enzymes, fine chemicals, or therapeutic proteins.
Highly efficient, site-specific genome modification for single and multiplex edits across the B. subtilis chromosome.
Stable, permanent inactivation (Knockout) of competing pathways and integration (Knock-in) of heterologous genes or optimized expression cassettes.
Accurate, double-strand break-free single nucleotide polymorphism (SNP) introduction for rational enzyme mutation or regulatory element tuning.
Rational design and engineering of metabolic routes to redirect carbon flux, reduce byproduct formation, and enhance precursor supply.
Systematic, high-plex deletion of multiple genes (e.g., proteases, competing pathway enzymes) to create streamlined production chassis.
Optimization of expression and secretion systems for high-yield production and purification of soluble, active recombinant proteins.
High-Throughput Screening (HTS) and automated selection to rapidly identify top-performing engineered clones.
Quantitative analysis (metabolomics, fluxomics) combined with predictive modeling (FBA, Kinetic Modeling) to guide rational strain design.
Reversible gene silencing tool used for functional studies and fine-tuning enzyme expression levels during pathway optimization experiments.
Data-Driven Rational Design
Every genetic edit is guided by Metabolic Modeling and Flux Analysis, maximizing the predictability of the outcome.
High-Plex Engineering Mastery
Expertise in simultaneous, marker-free Multi-Gene Knockout and large cassette Knock-in, essential for pathway integration.
Accelerated DBTL Cycle
Integration of CRISPR editing and HTS significantly reduces the number of R&D iterations, leading to faster strain delivery.
Guaranteed Industrial Performance
Final strains are fully verified for genetic stability, yield, and scalability under industrial fermentation conditions.
"The combination of their Kinetic Modeling and Multi-Gene Knockout service was seamless. The final strain showed a 30% increase in volumetric productivity exactly as predicted by the model."
Dr. Chen, Lead Bioprocess Engineer, Industrial Biocatalyst Firm
"We received a robust, marker-free B. subtilis chassis with all competing metabolic pathways eliminated. This clean background allowed our heterologous pathway to achieve maximum flux immediately."
Mr. David Smith, Project Manager, Metabolic Pathway Optimization Group
"Their HTS and validation assays were fast and accurate. We rapidly moved from the initial concept to a validated, scalable strain, meeting our tight regulatory deadlines."
Dr. Lena Koo, R&D Scientist, Synthetic Biology Startup
"The integrated approach is superior to piecing together services. CD Biosynsis managed the entire DBTL cycle, resulting in a stable, high-yield protein expression host for our therapeutic product."
Dr. Alan Rivas, Lab Director, Applied Microbiology Institute
What is the key advantage of an integrated solution over separate services?
Integration ensures that every genetic modification is guided by metabolic models and validated by functional assays. This minimizes costly trial-and-error iterations and guarantees a faster, more predictable path to a high-titer strain.
Which B. subtilis services are included in the Metabolic Engineering solution?
Our Metabolic Engineering solution typically includes Pathway Optimization, Multi-Gene Knockout, Gene Knock-in, and integration with Assay and Modeling services for rational design.
Do you guarantee the genetic stability of the final engineered strain?
Yes. We prioritize chromosomal integration for all major modifications and perform rigorous in vivo stability testing over multiple generations to ensure the final strain is stable and reliable for industrial scale-up.
Can you handle the entire DBTL cycle for my project?
Yes, we are equipped to manage the complete Design-Build-Test-Learn cycle, using computational modeling for design, CRISPR for building, HTS and assays for testing, and data analysis for learning and subsequent optimization.
What is the role of CRISPRi in the optimization process?
CRISPRi (Inhibition) is used as a reversible tool to fine-tune gene expression. It's ideal for quickly testing the impact of reduced enzyme activity on pathway flux before committing to a permanent gene knockout or mutation.
How do you verify the performance gain of the new strain?
Performance gain is quantitatively verified using controlled fermentation assays, measuring metrics such as final product titer, volumetric productivity, and substrate consumption via calibrated HPLC and GC-MS.
Do you offer solutions for optimizing protein secretion?
Yes. Our Protein Expression service focuses on optimizing the secretion signal peptide, removing competing proteases (multi-gene knockout), and balancing expression levels to maximize soluble protein yield in the medium.
What initial information is needed to start a project?
We require the target compound, the desired yield improvement, the parent B. subtilis strain (if applicable), and any known pathway genetics or expression data.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.